Connecting RNAi Leaders Worldwide To Showcase Breakthroughs, Spark Partnerships & Accelerate Innovation
Powering innovation in RNAi requires a dedicated community focused on the field's most pressing challenges. As the industry’s premier forum, the 7th RNAi-Based Therapeutics Summit is where this community converges to tackle the critical mission of translating siRNA and miRNA drugs beyond the liver.
Through deep engagement, we've identified their key pain points, from targeted extrahepatic delivery to late-stage CMC and clinical translation. Now, our attendees from 80+ leading biopharma companies and innovative biotech are actively seeking partners like you to provide solutions in:
- Novel Delivery Platforms for CNS, muscle, adipose, and renal tissues
- Oligonucleotide Synthesis to overcome complex CMC hurdles
- AI-Driven Discovery for novel target identification and validation
- Translational Models to de-risk clinical pathways for non-liver diseases
Can you help the industry with these challenges?
Partner with us in 2026 to elevate your brand and secure direct access to senior decision-makers from companies like Alnylam, Biogen, and Sanegene Bio, all actively investing in the next wave of RNAi therapeutics
Download Your Copy:
What the Summit Delivers for Partners
Distinguish Your Solutions
Stand out by demonstrating your expertise in overcoming the unique hurdles of RNAi therapeutic development. This is your platform to showcase advanced delivery platforms for precise tissue targeting, highlight capabilities in CMC and manufacturing excellence for regulatory compliance, and demonstrate powerful AI-driven discovery tools for next-generation target validation and candidate design.
Generate Commercial Opportunities
The 7th RNAi Summit is intentionally curated forum that fosters high-value connections between solution providers and the RNAi leaders who need them most. You’ll engage in meaningful discussions with senior executives from clinical-stage biotech like Gensaic, leveraging AI-designed ligands for muscle targeting, and Judo Bio, pioneering kidney-targeted silencing with their STRIKE™ platform, along with BD and R&D teams from Alnylam, Biogen, and AbbVie attending to identify partners who can de-risk their path to the clinic and beyond.
Accelerate and De-Risk Development
Become an integral partner in the preclinical and clinical pipeline by providing the critical data and services needed to build conviction. Showcase how your specialized tools, from single-cell RNA sequencing for validating the mechanism of action, to definitive bioanalytical services for overcoming CMC hurdles, and high-purity raw materials for synthesis, provide the essential proof and compliance data to move promising therapies forward with confidence.
Raise Your Brand Awareness
Showcase your solutions to the key opinion leaders and decision-makers who rely on specialized partners to solve critical challenges in extrahepatic delivery, novel chemistry, and scalable manufacturing.
Key Interest Areas
Raw Materials: Oligonucleotide & RNAi Synthesis, Reagents & Assays
Supply the high-purity starting materials, from phosphoramidites and custom nucleotides to specialized enzymes and assays, that are essential for efficiently synthesizing, stabilizing, and validating the next generation of complex siRNA and miRNA constructs.
Characterization & Bioanalytical Services
Provide the critical analytical data needed for regulatory success. Your LC/MS, SEC, and other services quantify payload integrity, impurity profiles, and stability to overcome CMC hurdles and ensure therapeutic efficacy for novel conjugates and formulations.
CDMO Services (CMC & Manufacturing, Fill/Finish)
Offer the operational expertise to scale novel RNAi modalities. As pioneers advance candidates with intricate chemistries, they seek CDMO partners who can navigate oligonucleotide synthesis, LNP formulation, and aseptic fill/finish to ensure a reliable path from clinic to commercial supply.
Single-cell RNA sequencing & Multi-Omics
Deliver unprecedented resolution into drug mechanism and safety. Your platforms enable developers to validate tissue-specific delivery, quantify target gene knockdown, and identify novel biomarkers, providing the critical proof-of-concept needed to de-risk preclinical candidates.
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Hannah Martin
Business Development Manager
Tel: +1 617 455 4188
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.